Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Keuntungan bersih Duopharma Biotech Bhd bagi suku ketiga berakhir 30 Sept 2023 (3QFY2023) turun 45.13% kepada RM8.97 juta daripada RM16.35 juta disebabkan kos kewangan yang lebih tinggi, antara lain. http://surl.li/looda
maybe buy on news also...bad news is all..
may upwards....good luck...I had zero holding in this counter ...stay sideline...think is glc so safe ? think again when all the management team are just doing basically xxx for company
Duopharma Biotech Bhd has received a six-month contract extension for the supply of pharmaceutical and non-pharmaceutical products to government-run hospitals and clinics. Seems like this counter is on attractive rates to buy for long term https://prnt.sc/0YHGsIwYO55J .